HIMS
Hims & Hers Health, Inc.NYSEHealthcare$19.14-3.53%OpenMarket Cap: $4.20B
As of 2026-04-06
Valuation
P/E (TTM)
32.74
PEG
17.73
P/B
8.03
P/S
1.79
EV/EBITDA
32.63
DCF Value
$112.19
FCF Yield
1.7%
Div Yield
0.0%
Margins & Returns
Gross Margin
73.8%
Operating Margin
4.5%
Net Margin
5.5%
ROE
23.0%
ROA
7.6%
ROIC
6.0%
Income Statement
| Period | Revenue | Gross Margin | Operating Income | Net Income | EPS | Dividend |
|---|---|---|---|---|---|---|
| Q4 2025 | $617.8M | 71.9% | $9.2M | $20.6M | $0.08 | — |
| FY 2025 | $2.35B | 73.8% | $105.6M | $128.4M | $0.51 | — |
| Q3 2025 | $599.0M | 73.8% | $11.8M | $15.8M | $0.06 | — |
| Q2 2025 | $544.8M | 76.4% | $26.7M | $42.5M | $0.17 | — |
| Q1 2025 | $586.0M | 73.5% | $57.9M | $49.5M | $0.20 | — |
| Q4 2024 | $481.1M | 76.8% | $18.6M | $26.0M | $0.11 | — |
| FY 2024 | $1.48B | 79.5% | $61.9M | $126.0M | $0.53 | — |
| Q3 2024 | $401.6M | 79.2% | $22.4M | $75.6M | $0.32 | — |
| Q2 2024 | $315.6M | 81.3% | $11.0M | $13.3M | $0.06 | — |
| Q1 2024 | $278.2M | 82.4% | $9.9M | $11.1M | $0.05 | — |
| Q4 2023 | $246.6M | 82.7% | $-400.0K | $1.2M | $0.01 | — |
| FY 2023 | $872.0M | 82.0% | $-29.5M | $-23.5M | $-0.11 | — |